Bristol-Myers Squibb and Otsuka have received approval to market an oral solution form of aripiprazole (Abilify®) for adults who cannot swallow tablets.
buy antibiotics canada

Aripiprazole is indicated for the treatment of schizophrenia and acute manic and mixed episodes associated with bipolar disorder. The product is the first dopamine partial agonist.

Random Posts:

• Plavix: Using a High Dose Sooner Rather Than Later
• Laronidase for Genetic Disease
• But Do SSRIs Cause Harm to Infants’ Lungs
• Anticoagulants Safe for Older Patients with Atrial Fibrillation
• Drug Interaction Warning for Repaglinide